603658 安圖生物
按盤價 
35.750 +0.040 (+0.112%) | 2025/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 3,127,156 | -7.48% | 4,471,203 | 4,443,656 | 4,441,627 | 3,765,917 | |
| 減：營業總成本 | 2,294,860 | -4.71% | 3,307,150 | 3,214,960 | 3,278,389 | 2,832,095 | |
| 其中:營業成本 | 1,099,754 | -5.22% | 1,546,574 | 1,559,713 | 1,783,657 | 1,525,628 | |
| 財務費用 | 6,266 | -19.37% | 1,679 | 8,788 | (2,041) | 14,589 | |
| 資產減值損失 | (12,968) | 84.56% | (62,954) | (32,692) | (35,777) | (619) | |
| 公允價值變動收益 | (2,656) | -124.82% | 3,610 | 580 | -- | 33 | |
| 投資收益 | 86,017 | 45.92% | 92,272 | 129,381 | 118,585 | 108,346 | |
| 其中：對聯營企業和合營企業的投資收益 | (1,359) | -69.62% | (6,261) | (3,369) | 2,000 | 76 | |
| 營業利潤 | 952,197 | -10.52% | 1,245,489 | 1,365,748 | 1,296,382 | 1,076,152 | |
| 利潤總額 | 959,174 | -9.02% | 1,289,056 | 1,362,544 | 1,293,715 | 1,065,549 | |
| 減：所得稅費用 | 86,449 | 1.89% | 89,823 | 138,413 | 105,033 | 85,693 | |
| 淨利潤 | 872,725 | -9.98% | 1,199,233 | 1,224,131 | 1,188,682 | 979,856 | |
| 減：非控股權益 | 13,210 | -0.36% | 4,781 | 6,692 | 21,245 | 6,193 | |
| 股東淨利潤 | 859,515 | -10.11% | 1,194,452 | 1,217,439 | 1,167,437 | 973,663 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.500 | -9.09% | 2.070 | 2.100 | 2.000 | 1.660 | |
| 每股派息 (元) * | -- | -- | 1.260 | 1.052 | 0.800 | 0.720 | |
| 每股淨資產 (元) * | 15.306 | 5.84% | 14.830 | 14.559 | 13.275 | 12.412 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 30/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
